Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-02

Clinical Trial Update: Effect of Fluid Deresuscitation With Central Venous Pressure Target 0-4 mmHg in Septic Shock Patients [NA]

View source ↗

Summary

A clinical trial evaluating fluid deresuscitation with a central venous pressure target of 0-4 mmHg in septic shock patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Indonesia University | Conditions: Septic Shock | NA | Status: COMPLETED